GlassScriptPhysician profile
James J Jackson
NPI 1760646392
$11,030.69
in general payments reported to CMS, 2019-2025
39 companies · $862 in 2025
The $862 reported for 2025 was more than what 86% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,435 · 2020: $800 · 2021: $586 · 2022: $5,601 · 2023: $1,563 · 2024: $184 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,545 · Travel and Lodging: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,545.40 |
| Travel and Lodging | $1,063.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $2,419.54 | 2022 | |
| Interventional Pain Technologies INC. | $1,614.95 | 2022 | |
| Si-Bone, INC. | $1,167.96 | 2022 | |
| Nevro Corp. | $801.93 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $727.59 | 2023-2025 | Iovera, Zilretta |
| Medtronic, INC. | $624.80 | 2021-2024 | Intellis Adaptivestim |
| Bard Peripheral Vascular, INC. | $585.56 | 2022-2023 | Venclose Maven Catheter |
| Arthrex, INC. | $482.45 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $332.33 | 2019-2022 | |
| Medtronic USA, INC. | $297.44 | 2019-2020 | |
| Abbott Laboratories | $259.31 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $226.01 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $217.76 | 2019-2021 | |
| Curonix LLC | $180.54 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $116.86 | 2019-2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $116.76 | 2025 | |
| Pacira Therapeutics, INC. | $94.82 | 2019-2021 | |
| Grt US Holding, INC. | $83.39 | 2020-2022 | |
| Tonix Medicines, INC. | $67.35 | 2025 | Tonmya |
| Smith+Nephew, INC. | $66.78 | 2020-2022 | |
| Bioventus LLC | $60.77 | 2019-2022 | |
| Virtus Pharmaceuticals LLC | $53.03 | 2021 | |
| Boston Scientific Corporation | $49.81 | 2019-2025 | Intracept |
| Kaleo, INC. | $42.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.43 | 2019 | |
| Redhill Biopharma INC. | $36.08 | 2020 | |
| Merck Sharp & Dohme LLC | $35.49 | 2020-2021 | |
| Orexo US, INC. | $29.09 | 2019 | |
| Ibsa Pharma INC. | $27.76 | 2021 | |
| Saluda Medical Americas, INC. | $23.83 | 2023 | Evoke Scs |
| Astrazeneca Pharmaceuticals LP | $23.58 | 2019-2020 | |
| Fidia Pharma USA INC. | $21.28 | 2025 | Hymovis |
| Radius Health, INC. | $20.56 | 2022 | |
| Daiichi Sankyo INC. | $19.24 | 2019 | |
| Horizon Therapeutics Plc | $14.09 | 2021 | |
| Almatica Pharma LLC | $13.87 | 2021 | |
| Lilly USA, LLC | $12.50 | 2019 | |
| Mdd US Operations, LLC | $11.14 | 2019 | |
| Pfizer INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.